Panic Disorders Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Choose License

Report Code: ZMR-1505 | Report Format : | Status : Upcoming |


Global Panic Disorders Market: Overview

When a patient suffers from frequent sudden panic attacks then that patient is suffering from the panic disorder which is a type of anxiety disorder. The patient has the following symptoms when panic attacks occur such as intense fear, sweating, shortness of breath, palpitations, shaking, numbness, etc. The reason or the cause for the panic attack is anonymous.

Global Panic Disorders Market: Segmentation

The panic disorder market is globally segmented into its type, drug class, and regions. On the basis of type, the global market is segregated into agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), bipolar disorder, post-traumatic stress disorder (PTSD), specific phobias, generalized anxiety disorder (GAD), and major depressive disorder. Based on the drug class, the market is categorized into selective serotonin reuptake inhibitor (SSRI), benzodiazepines (BZD), and serotonin-norepinephrine reuptake inhibitor (SNRI). The selective serotonin reuptake inhibitor (SSRI) is further sub-segmented into paroxetine (Paxil, Pexeva), fluoxetine (Prozac), and sertraline (Zoloft).

Global Panic Disorders Market: Growth Factors

The increasing awareness regarding the disorders, growing prevalence of the mental and anxiety disorders, and the availability of treatment options that are effective are some of the key factors that estimate to fuel the growth of the global panic disorders market. The increasing initiatives that are being taken by the leading players in order to create an understanding among the consumers will accelerate the growth of the market. In the recent years, several drugs are in different phases of clinical trials, which will be commercialized soon thus encouraging the growth of the market. On the other hand, in underdeveloped and developing economies there is a lack of awareness regarding the severity of these disorders if not treated is the major factor that is likely to restrict the overall growth of the market in the coming years.

Global Panic Disorders Market: Regional Analysis

North America predicts to lead the global panic disorders market and hold a huge share in the global market. The high growth in this region can be attributed to the factors such as the presence of a large number of players that are involved in this field and the increasing awareness among the consumers regarding the accessibility of the therapeutics that are effective for the panic disorders. Europe expects to remain in the second position. Asia Pacific projects witnessing robust growth in the coming years, owing to the unexploited lucrative opportunities for the key players. In addition, the expanding purchasing capacity of the consumers in the region expects to encourage the growth of the market. India and China anticipate contributing considerably towards the growth of the panic disorders market in Asia Pacific region.

Global Panic Disorders Market: Competitive Players

Some of the key market players that are involved in the panic disorders market include Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International, Inc., Pfizer, Inc., H. Lundbeck A/S, Actavis Plc., Sanofi, Eli Lilly and Company, Neurocrine Biosciences, Inc., Mylan, Inc., and AstraZeneca Plc.

Global Panic Disorders Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Healthcare M2M Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2632 | Report Format:

Global Healthcare M2M Market: Overview Machine-to-machine (M2M) technology is an extremely significant tool in the healthcare sector. Medical devices can enhance patient care skills and provide remote diagnostics, it can change health care in a lot of manners such as it needs a small quantity of...Read More

Healthcare IT Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2630 | Report Format:

Global Healthcare IT Outsourcing Market: Overview Outsourcing can be referred as the method in which a company chooses the most proficient third party to provide some selected services such as operational management, administrative services or data management. The healthcare industry is in its r...Read More

Intraocular Lens Market, by Type (Monofocal IOLs and Premium IOLs); By Application (Cataract Surgery, Refractive Lens Exchange Surgery, and Trauma Surgery); By Material (Polymethylmethacrylate (PMMA), Silicon, Hydrophobic Acrylic, and Hydrogel); By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Ophthalmology Clinics, and Eye Research Institutes): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2022

Feb-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2627 | Report Format:

Report Brief The report covers the forecast and analysis of the intraocular lens market on the global as well as regional level The report incorporates the positive and the negative factors that are affecting the growth of the market The market opportunities are discussed in detail in the repo...Read More

Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids and Others), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022.: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022

Feb-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2616 | Report Format:

The report covers forecast and analysis for the rheumatology therapeutics market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the rheumatology thera...Read More

ePharmacy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2604 | Report Format:

Global ePharmacy Market: Overview The ePharmacy, also popularly known as online pharmacy, or mail-order pharmacy, or Internet pharmacy, is a pharmacy operating via Internet and does the sending of orders to its customers via shipping companies or mail. ePharmacies include pharmacy benefit manage...Read More

Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Quick Inquiry